OPTIMAL THERAPEUTIC RANGE FOR ORAL ANTICOAGULANTS

被引：116
作者：
HIRSH, J
POLLER, L
DEYKIN, D
LEVINE, M
DALEN, JE
机构：
[1] UNIV ARIZONA,COLL MED,TUCSON,AZ 85721
[2] WITHINGTON HOSP,NATL REFERENCE LAB ANTICOAGULANT REAGENT & CONTROL,MANCHESTER M20 8LR,LANCS,ENGLAND
[3] VET ADM MED CTR JAMAICA PLAIN,BOSTON,MA 02130
[4] HAMILTON REG CANC CTR,HAMILTON,ONTARIO,CANADA
来源：
CHEST | 1989年 / 95卷 / 02期
关键词：
D O I：
10.1378/chest.95.2.5S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：S5 / S11
页数：7
相关论文
共 32 条
[1]  
[Anonymous], 1969, Br Med J, V1, P335
[2]  
BAILEY EL, 1971, CAN MED ASS J, V94
[3]  
BERN MM, 1986, SURGERY, V99, P216
[4]   EFFICACY OF ANTICOAGULANT THERAPY IN PREVENTING EMBOLISM RELATED TO DC ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION [J].
BJERKELUND, CJ ;
ORNING, OM .
AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (02) :208-+
[5]  
CONLEY CL, 1948, AM J MED SCI, V215, P158
[6]   ANTICOAGULANT THERAPY AFTER ACUTE MYOCARDIAL-INFARCTION - RELATION OF THERAPEUTIC BENEFIT TO PATIENTS AGE, SEX, AND SEVERITY OF INFARCTION [J].
DRAPKIN, A ;
MERSKEY, C .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 222 (05) :541-&
[7]   2-STEP WARFARIN THERAPY - PREVENTION OF POSTOPERATIVE VENOUS THROMBOSIS WITHOUT EXCESSIVE BLEEDING [J].
FRANCIS, CW ;
MARDER, VJ ;
EVARTS, CM ;
YAUKOOLBODI, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (03) :374-378
[8]  
FUSTER V, 1982, CIRCULATION
[9]  
GOGSTAD GO, 1986, THROMB HAEMOSTASIS, V56, P178
[10]   IS THE DOSE OF WARFARIN PRESCRIBED BY AMERICAN PHYSICIANS UNNECESSARILY HIGH [J].
HIRSH, J .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (04) :769-771
1234